Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
HLGN.WS was delisted on the 7th of November, 2023.
17 hedge funds and large institutions have $2.56M invested in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
63% less capital invested
Capital invested by funds: $7M → $2.56M (-$4.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBLIC
Security Benefit Life Insurance Company
Topeka,
Kansas
|
+$193K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$186K |
| 3 |
Jane Street
New York
|
+$1.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$29K |
| 2 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$14.8K |
| 3 |
HF
HRT Financial
New York
|
-$3.22K |
| 4 |
D.E. Shaw & Co
New York
|
-$2.64K |
HLGN.WS Hedge Fund Activity: Q2 2022 in Review
17 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) for Q2 2022, worth a combined $2.56M — down 63% from $7M a quarter earlier.
Fund positioning in HLGN.WS was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Security Benefit Life Insurance Company, opening a new position worth an estimated $193K. The largest seller was Yakira Capital Management, exiting entirely with an estimated $29K sold.
- 17 institutional investors held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $2.56M of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 stock for Q2 2022, down 63% quarter-over-quarter.
- 2 funds opened new Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 buyer in Q2 2022 was Security Benefit Life Insurance Company, an estimated $193K added.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 seller in Q2 2022 was Yakira Capital Management, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2022.